Xiuyan Wang
Director, Biotherapeutics Core Facility Memorial Sloan Kettering Cancer Center
Xiuyan Wang is Director of the BioTherapeutics Core Facility at Memorial Sloan Kettering Cancer Center. She has a demonstrated record of developing and advancing cell therapy for T cells and haematopoietic stem cells from pre-clinical stage to phase I/II clinical trials. She has over 18 years of hands-on cGMP experience supporting 20+ phase I/II clinical trials, with extensive expertise in CMC, FDA and NIH regulations, and large-scale manufacturing of clinical-grade viral vectors and gene-edited cell therapies.
Seminars
Tuesday 15th September 2026
Panel Discussion: Weighing the Pros & Cons of Automated Manufacturing
9:30 am
- Exploring the adoption of automated manufacturing process to enhance consistency, output and decrease variability
- Examining integration and flexibility challenges in automation to inform realistic implementation strategies
- Analyzing the impact of automation on cost of goods to optimize resource allocation and support sustainable clinical and commercial manufacturing
Tuesday 15th September 2026
Developing Cell Therapies Leveraging Automated Manufacturing to Reduce COGs while Maintaining Product Quality
9:00 am
- Discussing strategies to achieve the highest yield with automated manufacturing
- Exploring the stage of development at which to introduce automation
- Showcasing data achieved using automated manufacturing processes in CAR-T and CARNK therapies
